Hypoglycemia, Type2 Diabetes
Conditions
Brief summary
We will study the effect of hypoglycemia (low blood sugar) on baroreflex sensitivity in participants with well controlled type 2 diabetes.
Detailed description
Participants are admitted for two days and two nights to an inpatient clinical research center for performance of study procedures. On Day 1, two hyperinsulinemic hypoglycemic (50 mg/dl) clamps are performed - an AM clamp from about 9 to 11 am and a PM clamp from about 1 to 3 pm.. Modified Oxford procedures are performed in duplicate at five time points -- before the AM clamp, during the AM clamp, before the PM clamp, during the PM clamp, and the morning of Day 2 (about 16 hrs after completion of the the PM clamp). The Modified Oxford procedure involves the sequential intravenous administration of nitroprusside and phenylephrine with assessment of blood pressure and heart rate by finapress. Baroreflex sensitivity is the relationship of changes in heart rate to changes in blood pressure. .
Interventions
Participants will receive two 90 minute sessions of hypoglycemia. Baroreflex sensitivity will be assessed before, after, and during the sessions.
Sponsors
Beth Israel Deaconess Medical Center
National Heart, Lung, and Blood Institute (NHLBI)
National Center for Advancing Translational Sciences (NCATS)
Brigham and Women's Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No
Inclusion criteria
* Males and females age 18 to 55 years * Type 2 Diabetes Mellitus controlled by diet, exercise and non-insulin glycemic control agents (metformin, thiazolidinediones, sulfonylureas, dipeptidyl peptidase-4 inhibitors, sodium-glucose co-transporter 2 inhibitors, alpha-glucosidase inhibitors or glucagon-like peptide-1 receptor agonist) or basal insulin at doses less than or equal to 0.3 units/ kg per day.
Exclusion criteria
* Hemoglobin A1c \> 9% for type 2 diabetes * Recurrent hypoglycemic episodes within the past month * BMI \< 25 or \> 42 (Type 2 diabetes only) * Pregnancy * Lactation * Clinically significant coronary artery, cerebrovascular, or peripheral vascular disease, or presence of systemic illness that might affect autonomic function. Such illnesses include congestive heart failure, renal, pulmonary, hepatic disease, anemia, malignancies, untreated thyroid disease, and alcoholism. * Current major depressive illness * In all subjects, any individuals on oral, injected, inhaled or topical corticosteroids within the last year or oral contraceptives within the past 3 months will be excluded. * Known hypersensitivity to nitroglycerin, nitroprusside and/or phenylephrine. * Blood pressure \> 160/100 mmHg (applies to participants with T2 diabetes) * Creatinine \> 1.5 mg/dL * Serum potassium \>5.2 mmol/L * Estimated GFR \< 50 mL/min * Use of Viagra, Cialis, and similar drugs within 72 hours of admission. * Use of beta-blockers or mineralocorticoid receptor antagonists
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Modified Oxford Method Assessment of Baroreflex Function | Time 0 and 16 hours after hyperinsulinemic hypoglycemic clamps | Change in baroreflex sensitivity between the first assessment (pre-AM clamp on Day 1) and the final assessment (AM of Day 2, about 16 hours after the PM clamp) |
Countries
United States
Outcome results
None listed